Guidance on applications for COVID-19 drug clinical trials under the Regulations: Additional requirements (English, HTML)

View metadata and access the original English HTML file: Guidance on applications for COVID-19 drug clinical trials under the Regulations: Additional requirements.

Format

HTML

Access

file-only

Publisher-reported update

2023-10-28

This section of the guidance outlines the additional requirements for good clinical practices, qualified investigators, and labelling.

Access original file